We have identified you may not be viewing TRAVAX optimally because the browser you are using is unsupported - click here.
We have identified you may not be viewing TRAVAX optimally because the browser you are using is unsupported - click here.
The Pan American Health Organization (PAHO) reports continued transmission of chikungunya in countries in Central and South America.
The following countries have reported cases in the first 6 weeks of 2023:
Argentina: 32 cases
Belize: 46 cases
Bolivia: 101 cases
Brazil: 8 301 cases
Colombia: 8 cases
Guatemala: 40 cases
Nicaragua: 3 cases
Paraguay: 40 818 cases (15 deaths)
Peru: 83 cases
Venezuela: 13 cases
Chikungunya is a viral infection spread by mosquito bites that can cause acute fever and severe joint pain. There is no vaccine available against chikungunya.
All travellers to endemic regions are potentially at risk of chikungunya and should be aware of this infection. Aedes mosquitoes are particularly persistent and aggressive. They bite between dawn and dusk.
Travellers developing a fever during or on return from travel are advised to seek medical attention as soon as possible.
For further information see TRAVAX chikungunya page.
